| Dr Joseph R Deitz, MD | |
|
122 1st Ave Ste 600, Fairbanks, AK 99701 | |
| (907) 452-8251 | |
| Not Available |
| Full Name | Dr Joseph R Deitz |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 16 Years |
| Location | 122 1st Ave Ste 600, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932350691 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Maine | 7517875131 | 12 |
News Archive
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.
Researchers at Nagoya City University and Nagoya University Graduate Schools of Medicine in Japan studied the interrelationship between levels of depression symptoms, C-reactive protein (CRP) level, and pain, confirming a significant positive association between depressive symptoms and CRP level in RA.
The House Foreign Affairs Committee on Thursday voted to "reinstate a ban on providing foreign aid to groups that perform abortions or provide advice about the procedure," The Hill's "HealthWatch" blog reports on the "so-called 'global gag rule'".
SNSF Sinergia grant awarded to research groups in Switzerland and Norway to identify novel treatment strategies for children with aggressive brain tumors.
› Verified 2 days ago
| Entity Name | State Of Maine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699776146 PECOS PAC ID: 7517875131 Enrollment ID: O20040610001611 |
News Archive
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.
Researchers at Nagoya City University and Nagoya University Graduate Schools of Medicine in Japan studied the interrelationship between levels of depression symptoms, C-reactive protein (CRP) level, and pain, confirming a significant positive association between depressive symptoms and CRP level in RA.
The House Foreign Affairs Committee on Thursday voted to "reinstate a ban on providing foreign aid to groups that perform abortions or provide advice about the procedure," The Hill's "HealthWatch" blog reports on the "so-called 'global gag rule'".
SNSF Sinergia grant awarded to research groups in Switzerland and Norway to identify novel treatment strategies for children with aggressive brain tumors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph R Deitz, MD 122 1st Ave Ste 600, Fairbanks, AK 99701-4899 Ph: (907) 452-8251 | Dr Joseph R Deitz, MD 122 1st Ave Ste 600, Fairbanks, AK 99701 Ph: (907) 452-8251 |
News Archive
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.
Researchers at Nagoya City University and Nagoya University Graduate Schools of Medicine in Japan studied the interrelationship between levels of depression symptoms, C-reactive protein (CRP) level, and pain, confirming a significant positive association between depressive symptoms and CRP level in RA.
The House Foreign Affairs Committee on Thursday voted to "reinstate a ban on providing foreign aid to groups that perform abortions or provide advice about the procedure," The Hill's "HealthWatch" blog reports on the "so-called 'global gag rule'".
SNSF Sinergia grant awarded to research groups in Switzerland and Norway to identify novel treatment strategies for children with aggressive brain tumors.
› Verified 2 days ago
Dr. Patrick D Dean, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1650 Cowles Street, Fairbanks, AK 99701 Phone: 907-458-5415 | |
Janice Onorato, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1867 Airport Way, Ste 205, Fairbanks, AK 99701 Phone: 907-455-7003 Fax: 866-465-7729 | |
Monique Dase Smith, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-459-3800 | |
Ronald A Martino, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1919 Lathrop St, Ste 220, Fairbanks, AK 99701 Phone: 907-452-1739 Fax: 907-452-2384 | |
Adam Miguel Estevez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 160 Cowles St, Fairbanks Memorial Hospital, Fairbanks, AK 99701 Phone: 907-458-5525 Fax: 907-458-5514 | |
Dr. Sasha Elizabeth Ericksen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 122 1st Ave Ste 600, Fairbanks, AK 99701 Phone: 907-459-3800 Fax: 907-459-3810 | |
Jereme T. Vaughan, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3101 Lathrop St, Fairbanks, AK 99701 Phone: 907-459-4700 |